| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Dec 7, 2022 | Sell(S) | 400K | $1.00 | $400K | 12.9M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-012324) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NRX Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.